Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum DRI Healthcare Trust T.DHT.UN

Alternate Symbol(s):  DHTRF

Healthcare
DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term. Geographically, it has a presence... see more

TSX:DHT.UN - Post Discussion

DRI Healthcare Trust > Q2
View:
Post by mjh9413 on Aug 04, 2022 12:17am

Q2

How will market respond?

https://dricapital.com/investors/news-releases/dri-healthcare-trust-reports-second-quarter-2022-results/
Comment by HermannHaller on Aug 04, 2022 8:26am
Comments from Scotia analyst: DRI Healthcare Trust DHT.U-T: US$7.00 Target: US$14.00 Rating: Sector Outperform Q2/22 First Take: Strong Contribution from Zytiga Drives Q2 Beat OUR TAKE: Positive. Strong contribution from Zytiga drives Q2 beat; Pipeline update to come on tomorrow morning’s call. After the close, DRI reported Q2 results that were broadly ahead of expectations, with cash ...more  
Comment by mjh9413 on Aug 04, 2022 12:54pm
A tad disappointing. Don't like to see cash receipts/unit declining y/y as are  basis for spec div in q4 (and they are buying back units.) Can't see why Scotia expected such small Zytiga revs (they are semi-annual Qtrs 2 and 4)? On other side Vonjo will hopefully provide higher cash receipts in future qtrs. Income is pretty lumpy all round. Long term holder.
DRI Healthcare Trust
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities